MedPath

Transverse Coloplasty vs. Side-to-end Anastomosis Following Low Anterior Resection (LAR): CSAR Trial

Not Applicable
Conditions
Fecal Incontinence
Rectal Cancer
Rectal Neoplasms
Rectal Tumors
Interventions
Procedure: Side-to-End Anastomosis
Procedure: Transverse Coloplasty
Registration Number
NCT03074461
Lead Sponsor
Ludwig-Maximilians - University of Munich
Brief Summary

CSAR Trial's aim is to determine whether the transverse coloplasty pouch or the side-to-end anastomosis as rectal reservoir reconstruction offers the best functional results.

Detailed Description

This study directly compares two neorectal reservoir-techniques, the transverse coloplasty and the side-to-end anastomosis, in low anterior resection in distal rectal cancer for the first time. Its focus is on the functional results. Besides stool frequency, the quality of life, safety of the procedures and the usage of stool modulating drugs is monitored in an 12 months-follow up regime.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Scheduled low anterior resection in patients with distal rectal carcinoma and planned anastomosis in mid/distal third of rectum
  • Local curative approach
  • Normal continence preoperatively
  • Non-IBD-associated carcinoma
  • Possible sphincter salvage
  • Signed informed consent
Exclusion Criteria
  • Non-curative approaches
  • Emergency surgery in cases of tumor perforation, abscess, sepsis
  • Proximal rectal carcinoma (> 12 cm from anocutaneous line)
  • Lack of informed consent
  • Age <18 years
  • Inclusion in other trials with interference of endpoints
  • Life expectancy less than 24 months (as estimated by the treating physicians)
  • Pregnancy
  • Immunosuppression

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Side-to-EndSide-to-End AnastomosisSide-to-End Anastomosis as neorectal reconstruction technique in low anterior resection (LAR)
Transverse ColoplastyTransverse ColoplastyTransverse Coloplasty pouch as neorectal reconstruction technique in low anterior resection (LAR)
Primary Outcome Measures
NameTimeMethod
Stool frequencytime = 6 months postoperative

Between group differences in stool frequency at t = 6 months postoperative

Secondary Outcome Measures
NameTimeMethod
Postoperative complicationsthrough study completion (an average of 12 months postoperative)

* Septic intraabdominal complications related to anastomosis (anastomotic insufficiencies, suture insufficiencies, abscesses);

* Wound infection

Quality of Lifebaseline, postoperative (2-3 months, 6 months, 12 months)

Quality of Life with focus on colorectally specialized questionnaires

Antimotility drug usagebaseline, postoperative (2-3 months, 6 months, 12 months)

Usage of antimotility drugs (e.g. loperamide) evaluated by standardized questionnaires

Trial Locations

Locations (3)

Maria-Theresia-Klinik

🇩🇪

München, Bayern, Germany

Krankenhaus Barmherzige Brüder München

🇩🇪

München, Bayern, Germany

Klinikum der Universität München

🇩🇪

München, Bayern, Germany

© Copyright 2025. All Rights Reserved by MedPath